Delivery Order SPE2DB22D2206-SPE2DB25FHL36
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,219.89 contract is for the provision of Tobramycin 300 mg/5 ml ampules with a completion date of March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,119.26 firm fixed price contract is for the supply of 4,558,749,565 units of the drug Tobramycin 300 mg/5 ml ampules. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobramycin 300 mg/5 ml ampules, a pharmaceutical product, with a ceiling value of $3,579.54 and a completion date of April 1, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a $4,134.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobramycin 300 mg/5 ml ampule in 5 ml units. The order has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,434.99 firm fixed-price delivery order is for the supply of Tobramycin 300 mg/4 ml ampules, a critical antibiotic medication. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,563,742,464 units of Tobramycin 300 mg/5 ml ampules. The contract has a ceiling value of $1,511.67 and a completion date of February 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $28,502.07 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The order is for the supply of 4,564,261,702 units of the medication Tobramycin 300 mg/4 ml ampules. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, also holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,790.98 firm fixed-price contract is for the delivery of Tobramycin 1.2 GM vials, a pharmaceutical product used to treat bacterial infections. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which allows the agency to efficiently procure a...
The Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Tobramycin 300 mg/5 ml ampules. The $1,007.78 firm-fixed-price contract has a completion date of January 27, 2022 and was awarded on January 26, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Tobramycin 1.2 GM vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 25, 2025, with a ceiling value of $1,888.72. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...